Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function [Phase 1]

View source ↗

Summary

This Phase 1 trial studied whether prebiotics can alter the gut microbiome and support beta cell function in Type 1 diabetes, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indiana University | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19